Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC

Országos Onkológiai Intézet Ráth György u. 7_Investigational Site Number :3480002, Budapest

Veszprém Megyei Tüdőgyógyintézet 049/2 Hrsz_Investigational Site Number :3480004, Farkasgyepü

Investigational Site Number : 7240005, A Coruña

Investigational Site Number : 7240004, Madrid

Investigational Site Number : 7240001, Madrid

CHRU BREST 5 Avenue Foch_Investigational Site Number :2500003, Brest

Investigational Site Number : 7240007, Oviedo

Centre François Magendie Hôpital du Haut Lévèque Av.de Magellan_Investigational Site Number :2500001, Pessac

Investigational Site Number : 7240002, Las Palmas

Investigational Site Number : 3760002, Tel Aviv

KU Medical Center_Investigational Site Number :8400002, Westwood

Nemocnice AGEL Ostrava - Vitkovice Plicní oddělení Zalužanského 2214/35_Site Number :2030002, Ostrava - Vitkovice

Fakultní nemocnice Olomouc Onkologická klinika I.P. Pavlova 6_Site Number :2030001, Olomouc

Institut Sainte-Catherine 250 Chemin de Baigne-Pieds_Investigational Site Number :2500005, Avignon

Pôle régional de Cancérologie 2 rue de la Milèterie BP 577_Investigational Site Number :2500004, Poitiers

ONCOCENTRO APYS Av. La Marina 1702, 2do piso, Viña del Mar_Investigational Site Number :1520003, Viña del Mar

Centro de Investigacion y Desarrollo Oncologico (CIDO) Hochstetter 599 of. 602-603-1001, Temuco_Investigational Site Number :1520005, Temuco

Investigational Site Number : 3760001, Ramat Gan

Orlandi Oncologia General Salvo 159, Providencia_Investigational Site Number :1520002, Santiago

ICEGCLINIC Avenida Serafín Zamora 190 Torre B, piso 4. La Florida_Investigational Site Number :1520006, Santiago

Centro Avancado de Oncologia CECAN - Liga Contra o Cancer Site Number : 0760004, Natal

Investigational Site Number : 7240006, Badalona